Cookie Hinweis

Wir verwenden Cookies, um Ihnen ein optimales Webseiten-Erlebnis zu bieten. Dazu zählen Cookies, die für den Betrieb der Seite notwendig sind, sowie solche, die lediglich zu anonymen Statistikzwecken, für Komforteinstellungen oder zur Anzeige personalisierter Inhalte genutzt werden. Sie können selbst entscheiden, welche Kategorien Sie zulassen möchten. Bitte beachten Sie, dass auf Basis Ihrer Einstellungen womöglich nicht mehr alle Funktionalitäten der Seite zur Verfügung stehen. Weitere Informationen finden Sie in unseren Datenschutzhinweisen .

Essentiell

Diese Cookies sind für die Funktionalität unserer Website erforderlich und können nicht deaktiviert werden.

Name Webedition CMS
Zweck Dieses Cookie wird vom CMS (Content Management System) Webedition für die unverwechselbare Identifizierung eines Anwenders gesetzt. Es bietet dem Anwender bessere Bedienerführung, z.B. Speicherung von Sucheinstellungen oder Formulardaten. Typischerweise wird dieses Cookie beim Schließen des Browsers gelöscht.
Name econda
Zweck Session-Cookie für die Webanalyse Software econda. Diese läuft im Modus „Anonymisiertes Messen“.
Statistik

Diese Cookies helfen uns zu verstehen, wie Besucher mit unserer Webseite interagieren, indem Informationen anonym gesammelt und analysiert werden. Je nach Tool werden ein oder mehrere Cookies des Anbieters gesetzt.

Name econda
Zweck Measure with Visitor Cookie emos_jcvid
Externe Medien

Inhalte von externen Medienplattformen werden standardmäßig blockiert. Wenn Cookies von externen Medien akzeptiert werden, bedarf der Zugriff auf diese Inhalte keiner manuellen Zustimmung mehr.

Name YouTube
Zweck Zeige YouTube Inhalte
Name Twitter
Zweck Twitter Feeds aktivieren

What the thymus can do on its own: Scientists from the German Cancer Research Center prove a dogma of immunology wrong

No. 38 | 10/07/2012 | by Sel

Special white blood cells called T lymphocytes (‘T’ stands for thymus derived) originate, like all other blood cells, from progenitor cells in the bone marrow. The cells then mature in the thymus gland, an organ of the immune system located in the upper chest, to become active immune cells. Conventional wisdom has held that the thymus is unable to produce T cells without constant supply from the bone marrow. Scientists from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) in Heidelberg have now managed to prove this dogma wrong by showing that the thymus is obviously capable of producing mature T cells for several months without any supply from the bone marrow. The group has now reported their results in the Journal of Experimental Medicine.

© dkfz.de

The thymus gland is an organ about the size of a fist that lies behind the breastbone. It is a central part of the immune system and it is the place where T lymphocytes develop into active cells of the immune system. Only cells that are able to discriminate between self and non-self are allowed to leave the thymus so that they can eliminate infected or cancerous cells while tolerating the body’s self tissues.

“Normally, immature T progenitor cells migrate into the thymus where they mature,” says Hans-Reimer Rodewald, head of the Division of Cellular Immunology at DKFZ. “Now we wanted to find out what happens if the thymus is not supplied with new progenitors.” To this end, Vera Martins, Hans-Reimer Rodewald and their colleagues studied genetically modified mice that do not have any lymphocyte progenitor cells in the bone marrow. Into these animals, the investigators transplanted thymus glands from normal mice. They expected the donor thymus to deliver its own mature cells into the recipient animal’s blood for a period of about four weeks. After that period, the thymus gland would have used up all of its own T cells and would degenerate.

“The estimated period of four weeks is based on the observation that in a thymus gland transplantation between two normal animals, the donor thymus exports its own T cells into the recipient’s blood for no more than four weeks. After that, the recipient’s own T cell progenitors will migrate from the bone marrow into the donor thymus and mature there,” Rodewald explains.

Surprisingly, however, the donor thymus in this experiment continued to produce its own donor T cells for at least three months. Apparently, there are immature progenitor cells present in the thymus gland which renew themselves in the absence of supply from the bone marrow and from which further T cells can mature. Presumably, the thymus gland serves as a ‘reservoir’ to make sure that the body does not have to stop its continuous production of these important immune cells if there is a weakness in the bone marrow. Whether this striking observation also applies to humans, is not yet known, but: “The thymus glands of mouse and man are very similar in structural and functional respects,” Rodewald explains.

The commonly held assumption that the thymus gland is unable to produce its own T cells on a continuing basis is probably due to the animal models that were available until now: “There were no mice without any T cell progenitors,” says Rodewald. “Therefore, we were unable to find out what happens to the thymus when there is no supply.”

In a next step, the researchers will try to find out which cells in the thymus gland develop into mature T cells if there is no supply and in which corner of the thymus they hide themselves. “This opens up a whole new research field for us,” says Rodewald. “And I am sure that we are in for more surprises.”

Vera C. Martins, Eliana Ruggiero, Susan M. Schlenner, Vikas Madan, Manfred Schmidt, Pamela J. Fink, Christof von Kalle, and Hans-Reimer Rodewald: Thymus-autonomous T cell development in the absence of progenitor import, Journal of Experimental Medicine, doi: 10.1084/jem.20120846

With more than 3,000 employees, the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) is Germany’s largest biomedical research institute. DKFZ scientists identify cancer risk factors, investigate how cancer progresses and develop new cancer prevention strategies. They are also developing new methods to diagnose tumors more precisely and treat cancer patients more successfully. The DKFZ's Cancer Information Service (KID) provides patients, interested citizens and experts with individual answers to questions relating to cancer.

To transfer promising approaches from cancer research to the clinic and thus improve the prognosis of cancer patients, the DKFZ cooperates with excellent research institutions and university hospitals throughout Germany:

  • National Center for Tumor Diseases (NCT, 6 sites)
  • German Cancer Consortium (DKTK, 8 sites)
  • Hopp Children's Cancer Center (KiTZ) Heidelberg
  • Helmholtz Institute for Translational Oncology (HI-TRON Mainz) - A Helmholtz Institute of the DKFZ
  • DKFZ-Hector Cancer Institute at the University Medical Center Mannheim
  • National Cancer Prevention Center (jointly with German Cancer Aid)
The DKFZ is 90 percent financed by the Federal Ministry of Education and Research and 10 percent by the state of Baden-Württemberg. The DKFZ is a member of the Helmholtz Association of German Research Centers.

RSS-Feed

Subscribe to our RSS-Feed.

to top
powered by webEdition CMS